EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Mechanisms and Strategies to Overcome Drug Resistance in Colorectal Cancer

Jennifer Haynes, Prasath Manogaran

International Journal of Molecular Sciences · 25.02.2025 · 26 (5) · 1988

DOI: 10.3390/ijms26051988 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 25.02.2025. Verfasst von Jennifer Haynes und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Clinical and Translational Sciences, Joan C. Edwards School of Medicine, Marshall University, 1600 Medical Center Drive, Huntington, WV…. Hauptthemen laut MEDLINE: Colorectal Neoplasms, Drug Resistance, Neoplasm, Antineoplastic Agents. Die Arbeit wurde bisher 88-mal zitiert (Crossref) und nennt 242 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Colorectal cancer (CRC) is a major cause of cancer-related mortality worldwide, with a significant impact on public health. Current treatment options include surgery, chemotherapy, radiotherapy, molecular-targeted therapy, and immunotherapy. Despite advancements in these therapeutic modalities, resistance remains a significant challenge, often leading to treatment failure, poor progression-free survival, and cancer recurrence. Mechanisms of resistance in CRC are multifaceted, involving genetic mutations, epigenetic alterations, tumor heterogeneity, and the tumor microenvironment. Understanding these mechanisms at the molecular level is crucial for identifying novel therapeutic targets and developing strategies to overcome resistance. This review provides an overview of the diverse mechanisms driving drug resistance in sporadic CRC and discusses strategies currently under investigation to counteract this resistance. Several promising strategies are being explored, including targeting drug transport, key signaling pathways, DNA damage response, cell death pathways, epigenetic modifications, cancer stem cells, and the tumor microenvironment. The integration of emerging therapeutic approaches that target resistance mechanisms aims to enhance the efficacy of current CRC treatments and improve patient outcomes.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Colorectal NeoplasmsDrug Resistance, NeoplasmAntineoplastic AgentsHumansTumor MicroenvironmentEpigenesis, GeneticSignal TransductionAnimalsNeoplastic Stem CellsMolecular Targeted Therapy

Stichwörter der Autor:innen

chemotherapycolorectal cancerdrug resistanceimmunotherapyresistance mechanismstargeted therapytherapeutic strategies

Substanzen

Antineoplastic Agents

Autor:innen und Institutionen

  • Department of Clinical and Translational Sciences, Joan C. Edwards School of Medicine, Marshall University, 1600 Medical Center Drive, Huntington, WV 25701, USA.

Zitieren

APA

Haynes, J., & Manogaran, P. (2025). Mechanisms and Strategies to Overcome Drug Resistance in Colorectal Cancer. International Journal of Molecular Sciences, 26(5), 1988. https://doi.org/10.3390/ijms26051988

Vancouver

Haynes J, Manogaran P. Mechanisms and Strategies to Overcome Drug Resistance in Colorectal Cancer. International Journal of Molecular Sciences. 2025;26(5):1988. doi:10.3390/ijms26051988

BibTeX
@article{Haynes2025,
  author = {Haynes, Jennifer and Manogaran, Prasath},
  title = {Mechanisms and Strategies to Overcome Drug Resistance in Colorectal Cancer},
  journal = {International Journal of Molecular Sciences},
  year = {2025},
  volume = {26},
  number = {5},
  pages = {1988},
  doi = {10.3390/ijms26051988}
}
Kostenlos starten →